Zobrazeno 1 - 5
of 5
pro vyhledávání: ''
Publikováno v:
The Journal of Pediatrics. 125:117-122
To compare the efficacy of dopamine and dobutamine for the treatment of hypotension (mean arterial blood pressure,or = 30 mm Hg) in preterm (or = 34 weeks of gestation) infants with respiratory distress syndrome in the first 24 hours of life, we enro
Publikováno v:
The Journal of Pediatrics. 121:98-102
To determine whether prophylactic treatment with recombinant human erythropoietin (rHuEPO) and iron would reduce the need for blood transfusions, we randomly assigned 22 premature infants with gestational ages less than or equal to 32 weeks and birth
Autor:
Kevin Shannon, Robert I. Abels, Sharon Decelle, Roderic H. Phibbs, Marcia Wertz, Wen Yi Li, Dorothy Thompson, Jodie Thayer-Moriyama, William C. Mentzer
Publikováno v:
The Journal of Pediatrics. 120:586-592
We randomly assigned eight concurrently symptom-free premature infants (birth weight less than or equal to 1250 gm) at high risk of requiring erythrocyte transfusions for anemia of prematurity to 6 weeks of intensive treatment with either subcutaneou
Autor:
Nancy Newton, Kevin Shannon, Susan Sniderman, Roderic H. Phibbs, Roberta A. Ballard, Robert I. Abels, Patricia Freeman, William C. Mentzer, Dorothy Thompson
Publikováno v:
The Journal of Pediatrics. 118:949-955
Experimental and clinical data implicate inadequate erythropoietin production as an important reason that infants acquire this anemia and suggest that recombinant human erythropoietin (r-HuEPO) might be used to treat or prevent it. We therefore rando
Autor:
Dimitrios Tsakiris, Chaido Tsantali, Vassiliki Soubasi, Elissavet Diamanti, Kosmas Sarafidis, George Kremenopoulos
Publikováno v:
The Journal of pediatrics. 127(2)
Treatment with recombinant human erythropoietin (rHuEPO) stimulates erythropoiesis and reduces the need for transfusions in hospitalized preterm infants. The aim of our study was to follow very low birth weight infants after the initial 6 weeks of rH